A Clinical trial to evaluate the efficacy of Siddha drugs Gandhaga Rasayanam (Internal) & Navanatha sittha thailam (External) in patients having multiple joint pain
Phase 2
Recruiting
- Conditions
- Patients having arthritis of three or more joints , Patients having RA factor POSITIVE , morning stiffness, CRP positive and anemia.
- Registration Number
- CTRI/2017/05/008469
- Lead Sponsor
- Govt siddha medical college
- Brief Summary
It is a Non Randomized open clinical trial. During this trial period 500 mg of Gandhaga Rasayanam (Internal) with hot water, twice a day and 10 ml of Navanatha Sittha thailam (External) is administered for 48 days in patients having Uthiravatha suronitham (Rheumatoid arthritis). All the details regarding the study will be documented and the result will be published.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Patients having arthritis of 3 or more joints 2.
- Morning stiffness 3.
- RA factor positive 4.
- C-Reactive Protein (CRP) positive 5.
- Anti Cyclic Citrullinated Peptide (Anti CCP) Positive 5.
- Patients who are willing to undergo laboratory investigations.
Exclusion Criteria
- Rheumatic fever 2.
- History of sulphur allergy 3.
- Psoriatic arthropathica, 4.
- Progressive systemic sclerosis 5.
- Gouty arthritis, 6.
- Pregnancy and lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in pain and swelling and morning stiffness 12months
- Secondary Outcome Measures
Name Time Method To study the safety parameters of the drug before and after treatment 12months
Trial Locations
- Locations (1)
Arignar Anna Hospital of Indian Medicine and Homoeopathy
🇮🇳Chennai, TAMIL NADU, India
Arignar Anna Hospital of Indian Medicine and Homoeopathy🇮🇳Chennai, TAMIL NADU, IndiaDr M ShrisaranyaPrincipal investigator8098372738drshrisaranya@gmail.com